arrow
D

Duncan Purtill

fiona stanley hospital
H指数:22
被引数:2,359

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell committee

预处理方案在自体和离体转基因造血干细胞治疗中的作用: 来自ISCT干细胞委员会的建议

2025-01-010
OAAI
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
2024-12-030
OAAI
Prior Azacitidine and Ongoing Transfusion Dependence in MDS Patients Are Associated with Inferior Survival after Allogeneic Stem Cell Transplant

既往接受阿扎胞苷治疗及持续输血依赖的MDS患者,与异基因造血干细胞移植后的较差生存相关。

BLOOD
IF23.1
2024-11-050
PRE
Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Ibrutinib加利妥昔单抗和mini-CHOP治疗新诊断DLBCL的老年患者: 一项2期ALLG研究

2024-11-010
PRE
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell–based genomic therapies and the challenges faced

国际细胞与基因治疗学会干细胞工程委员会关于基于造血干细胞和祖细胞的基因组疗法的现状和面临的挑战的报告

2024-11-015
PRE
Strategic infection prevention after genetically modi fi ed hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee

基因修饰造血干细胞治疗后的战略性感染预防: 国际细胞与基因治疗学会干细胞工程委员会的建议

2024-07-011
OAAI
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors
2024-05-095
OAAI
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update

移植和细胞治疗长期幸存者的筛查和预防实践的国际建议: 2023更新

2024-04-0115
OAAI
How comparable are patient outcomes in the real-world with populations studied in pivotal AML trials?
2024-03-260
OAAI
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host- disease after hematopoietic stem cell transplant

国际细胞与基因治疗学会干细胞工程委员会: 细胞疗法治疗造血干细胞移植后的移植物抗宿主病

2023-06-014
OAAI